OneMedNet Corporation (ONMD) AI Stock Analysis

OneMedNet Corporation, based in Eden Prairie, Minnesota, provides advanced clinical imaging solutions tailored for medical and academic research institutions. Its flagship offering, iRWD, uses artificial intelligence to securely de-identify, search, and curate imaging data. The platform supports a partner network that assists medical research, discovery, and diagnostics across the life sciences spectrum. iRWD facilitates collaboration and data sharing among healthcare professionals and researchers, aiming to improve clinical workflow efficiency and accelerate insights into disease progression and treatment outcomes.

Revenue rose from $1.1M in FY2021 to $1.2M in FY2022, before dropping to $1.0M in FY2023 and $643,000 in FY2024. In FY2025, revenue grew 111.4% to $1.4M, with a gross margin of -37.0% and an operating margin of -711.3%. Net income was -$2.8M in FY2025, narrowing from -$10.1M in FY2024 and -$23.2M in FY2023. Over the 5-year period from FY2020 to FY2025, revenue generated a compound annual growth rate of 10.5%. For the trailing twelve months ended June 30, 2026, revenue was $1.5M, with quarterly revenue growing 88.4% year-over-year.

As of June 30, 2026, OneMedNet had $358,000 in cash and short-term investments, total debt of $701,000, and net debt of $343,000. Shareholders' equity was -$3.5M, and total assets stood at $1.4M, resulting in a current ratio of 0.28. In FY2025, operating cash flow was -$7.5M, free cash flow was -$7.5M, and capital expenditures were $13,000. The company raised $312,000 from share issuance during FY2025, while its share count declined 61.2% over 5 years.

With a market cap of $26.3M and an enterprise value of $39.1M, OneMedNet trades at a price-to-sales ratio of 18.1x, compared to the median of 4.1x for its US-listed Healthcare peers. Its EV-to-EBITDA stands at 16.7x, above the peer median of 12.0x, while its EV-to-revenue ratio is 26.9x. The stock closed at $4.51 on October 16, 2026, down 82.5% over the past year and 59.0% year-to-date, trailing the S&P 500 (SPY) 1-year return of 16.8%.

OneMedNet has beaten EPS estimates in 1 of the last 4 quarters. The company's next earnings date is scheduled for November 13, 2026. For the trailing twelve months, diluted earnings per share was -$1.60.

This page is an AI-written research summary of OneMedNet Corporation (ONMD). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: ONMD income statement, ONMD balance sheet, ONMD key metrics, ONMD chart. See the ONMD stock overview for the latest quote and news.